VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $20,050,000 | +13.1% | 112,402 | +40.8% | 5.34% | +33.7% |
| Q2 2015 | $17,734,000 | +26.1% | 79,830 | +12.8% | 3.99% | +11.7% |
| Q1 2015 | $14,060,000 | +65.4% | 70,788 | +19.2% | 3.58% | +52.4% |
| Q4 2014 | $8,499,000 | -0.2% | 59,387 | -8.5% | 2.35% | -11.6% |
| Q3 2014 | $8,519,000 | -32.8% | 64,934 | -32.5% | 2.65% | -54.4% |
| Q1 2014 | $12,686,000 | +58.3% | 96,227 | +40.9% | 5.82% | -2.1% |
| Q4 2013 | $8,015,000 | – | 68,273 | – | 5.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |